|
|
 |
|
Viewing report
|
|
|
|
Medical Affairs Excellence: Structuring, Funding, & Aligning for Global Success
Best Practices LLC, May 2004, Pages: 56
In today's challenging healthcare environment, medical affairs' role has become even more crucial to pharmaceutical companies' success. Confronted with declining R&D productivity, escalating development costs, increasing competition, growing price pressures and intensified regulatory and public scrutiny, pharmaceutical companies seek to maintain double-digit revenue and earnings growth demanded by investors. In addition, companies are reallocating resources in response to Office of Inspector General (OIG) guidelines. This study uncovers how leading companies are working to align, staff and fund medical affairs capabilities to respond to these challenges.
Product samples
A sample for this product is available. Please Login/Register to download this sample.
Customers who bought this item also bought
Medical Affairs: Delivering Strategic Value
Medical Affairs Resources, Structures and Trends
Maintaining a Competitive Edge in Pharmaceutical Public Affairs: Benchmarking the Resources Required to Serve the U.S. Market
Pharmaceutical Regulatory Affairs in the EU & US
Medical Product Regulatory Affairs: Pharmaceuticals, Diagnostics, Medical Devices
Veterans Affairs: Agency Account Planner
China Water Affairs Group Limited
Pharmaceutical Pricing, Reimbursement, and Regulatory Affairs News in the Fourth Quarter of 2004
Massively Multiplayer Games - State of Affairs & Outlook
Best Practices for Government Affairs and Lobbying: Video Leadership Seminar with Caren Turner of Turner Government & Public Affairs (DVD)
Global Trends in Reimbursement of Medical Technology
Emerging Medical Technologies Report
|
|
|
|
